ARK Investment Management LLC - Sep 30, 2025 SCHEDULE 13G/A Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager
ARK Investment Management LLC
Reporting Manager
ARK Investment Management LLC
Security
CRISPR Therapeutics AG Common Stock
Symbol
CRSP
Shares outstanding
91M shares
Disclosed Ownership
9.79M shares
Ownership
10.8%
Form type
SCHEDULE 13G/A
Date filed
11/4/2025, 04:48 PM
Date of event
Sep 30, 2025
Previous filing
May 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARK Investment Management LLC 10.76% 9.79M 9.12M 211K /s/ Kellen Carter Kellen Carter, Chief Compliance Officer
Catherine D. Wood 10.76% 9.79M 0 9.33M /s/ Catherine D. Wood Catherine D. Wood, Chief Executive Officer, Chief Investment Officer